MYRIAD GENETICS, INC. Sales Revenue, Services, Net (Deprecated 2018-01-31)
MYRIAD GENETICS, INC. (MYGN) reported Sales Revenue, Services, Net (Deprecated 2018-01-31) of $179.70 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueServicesNet · last filed 2018-05-09
- MYRIAD GENETICS, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $179.70M, a 2.97% decline year-over-year.
- MYRIAD GENETICS, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $179.20M, a 2.56% decline year-over-year.
- MYRIAD GENETICS, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $178.80M, a 8.30% increase year-over-year.
- MYRIAD GENETICS, INC. sales revenue, services, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $187.90M, a 8.18% increase year-over-year.
- MYRIAD GENETICS, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2017 was $722.10M, a 2.32% increase from fiscal 2016.
- MYRIAD GENETICS, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2016 was $705.70M, a 1.47% increase from fiscal 2015.
- MYRIAD GENETICS, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2015 was $695.50M, a 7.04% decline from fiscal 2014.
- MYRIAD GENETICS, INC. sales revenue, services, net (deprecated 2018-01-31) for fiscal 2014 was $748.20M, a 28.47% increase from fiscal 2013.
| Period end | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 3 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 6 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 9 month as first filed | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month | Sales Revenue, Services, Net (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $179.70M 10-Q · filed 2018-05-09 | $358.90M derived: sum of 2 quarters · filed 2018-05-09 | $537.60M 10-Q · filed 2018-05-09 | $725.60M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-12-31 | $179.20M 10-Q · filed 2018-02-07 | $358.00M 10-Q · filed 2018-02-07 | $545.90M derived: sum of 3 quarters · filed 2018-02-07 | $731.10M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-09-30 | $178.80M 10-Q · filed 2017-11-08 | $366.70M derived: sum of 2 quarters · filed 2017-11-08 | $551.90M derived: sum of 3 quarters · filed 2018-05-09 | $735.80M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-06-30 | $187.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $373.10M derived: sum of 2 quarters · filed 2018-05-09 | $557.00M derived: sum of 3 quarters · filed 2018-05-09 | $722.10M 10-K · filed 2017-08-09 | ||||
| 2017-03-31 | $185.20M 10-Q · filed 2018-05-09 | $369.10M derived: sum of 2 quarters · filed 2018-05-09 | $534.20M 10-Q · filed 2018-05-09 | $707.90M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2016-12-31 | $183.90M 10-Q · filed 2018-02-07 | $348.90M 10-Q · filed 2018-02-07 | $522.70M derived: sum of 3 quarters · filed 2018-02-07 | $700.10M derived: sum of 4 quarters · filed 2018-02-07 | ||||
| 2016-09-30 | $165.10M 10-Q · filed 2017-11-08 | $338.80M derived: sum of 2 quarters · filed 2017-11-08 | $516.20M derived: sum of 3 quarters · filed 2017-11-08 | $698.80M derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | $173.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $351.10M derived: sum of 2 quarters · filed 2017-08-09 | $533.70M derived: sum of 3 quarters · filed 2017-08-09 | $705.70M 10-K · filed 2017-08-09 | ||||
| 2016-03-31 | $177.40M 10-Q · filed 2017-05-03 | $360.00M derived: sum of 2 quarters · filed 2017-05-03 | $532.00M 10-Q · filed 2017-05-03 | $710.80M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-12-31 | $182.60M 10-Q · filed 2017-02-08 | $354.50M 10-Q · filed 2017-02-08 | $533.40M derived: sum of 3 quarters · filed 2017-08-09 | $706.40M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-09-30 | $171.90M 10-Q · filed 2016-11-02 | $350.80M derived: sum of 2 quarters · filed 2017-08-09 | $523.80M derived: sum of 3 quarters · filed 2017-08-09 | $703.00M derived: sum of 4 quarters · filed 2017-08-09 | ||||
| 2015-06-30 | $178.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-08-09 | $351.90M derived: sum of 2 quarters · filed 2017-08-09 | $531.10M derived: sum of 3 quarters · filed 2017-08-09 | $695.50M 10-K · filed 2017-08-09 | ||||
| 2015-03-31 | $173.00M 10-Q · filed 2016-05-04 | $172.98M 10-Q · filed 2015-05-06 | $352.20M derived: sum of 2 quarters · filed 2016-05-04 | $516.60M 10-Q · filed 2016-05-04 | $516.63M 10-Q · filed 2015-05-06 | $699.57M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2014-12-31 | $179.20M 10-Q · filed 2016-02-03 | $179.15M 10-Q · filed 2015-02-04 | $343.60M 10-Q · filed 2016-02-03 | $343.66M 10-Q · filed 2015-02-04 | $526.57M derived: sum of 3 quarters · filed 2016-08-10 | $702.76M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2014-09-30 | $164.50M 10-Q · filed 2015-11-04 | $164.51M 10-Q · filed 2014-11-05 | $347.37M derived: sum of 2 quarters · filed 2016-08-10 | $523.56M derived: sum of 3 quarters · filed 2016-08-10 | $719.71M derived: sum of 4 quarters · filed 2016-08-10 | |||
| 2014-06-30 | $182.87M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-10 | $359.06M derived: sum of 2 quarters · filed 2016-08-10 | $555.21M derived: sum of 3 quarters · filed 2016-08-10 | $748.20M 10-K · filed 2016-08-10 | $748.20M 10-K · filed 2014-08-13 | |||
| 2014-03-31 | $176.19M 10-Q · filed 2015-05-06 | $372.35M derived: sum of 2 quarters · filed 2015-05-06 | $565.34M 10-Q · filed 2015-05-06 | $731.43M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-12-31 | $196.16M 10-Q · filed 2015-02-04 | $389.14M 10-Q · filed 2015-02-04 | $555.24M derived: sum of 3 quarters · filed 2015-08-12 | $703.63M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-09-30 | $192.99M 10-Q · filed 2014-11-05 | $359.08M derived: sum of 2 quarters · filed 2015-08-12 | $507.47M derived: sum of 3 quarters · filed 2015-08-12 | $648.12M derived: sum of 4 quarters · filed 2015-08-12 | ||||
| 2013-06-30 | $166.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-12 | $314.48M derived: sum of 2 quarters · filed 2015-08-12 | $455.13M derived: sum of 3 quarters · filed 2015-08-12 | $582.40M 10-K · filed 2015-08-12 | $582.39M 10-K · filed 2013-08-14 | |||
| 2013-03-31 | $148.38M 10-Q · filed 2014-05-07 | $289.04M derived: sum of 2 quarters · filed 2014-05-07 | $416.30M 10-Q · filed 2014-05-07 | $543.80M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-12-31 | $140.65M 10-Q · filed 2014-02-05 | $267.92M 10-Q · filed 2014-02-05 | $395.42M derived: sum of 3 quarters · filed 2014-08-13 | $518.73M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-09-30 | $127.27M 10-Q · filed 2013-11-12 | $254.77M derived: sum of 2 quarters · filed 2014-08-13 | $378.08M derived: sum of 3 quarters · filed 2014-08-13 | $495.69M derived: sum of 4 quarters · filed 2014-08-13 | ||||
| 2012-06-30 | $127.50M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-13 | $250.81M derived: sum of 2 quarters · filed 2014-08-13 | $368.42M derived: sum of 3 quarters · filed 2014-08-13 | $472.39M 10-K · filed 2014-08-13 | ||||
| 2012-03-31 | $123.31M 10-Q · filed 2013-05-08 | $240.92M derived: sum of 2 quarters · filed 2013-05-08 | $344.89M 10-Q · filed 2013-05-08 | $450.26M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-12-31 | $117.61M 10-Q · filed 2013-02-06 | $221.58M 10-Q · filed 2013-02-06 | $326.95M derived: sum of 3 quarters · filed 2013-08-14 | $429.33M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-09-30 | $103.97M 10-Q · filed 2012-11-09 | $209.34M derived: sum of 2 quarters · filed 2013-08-14 | $311.72M derived: sum of 3 quarters · filed 2013-08-14 | $412.16M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-06-30 | $105.37M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | $207.75M derived: sum of 2 quarters · filed 2013-08-14 | $308.19M derived: sum of 3 quarters · filed 2013-08-14 | $400.05M 10-K · filed 2013-08-14 | ||||
| 2011-03-31 | $102.37M 10-Q · filed 2012-05-02 | $202.81M derived: sum of 2 quarters · filed 2012-05-02 | $294.67M 10-Q · filed 2012-05-02 | |||||
| 2010-12-31 | $100.44M 10-Q · filed 2012-02-01 | $192.30M 10-Q · filed 2012-02-01 | ||||||
| 2010-09-30 | $91.86M 10-Q · filed 2011-11-02 | |||||||
| 2010-06-30 | $362.65M 10-K · filed 2012-08-15 | |||||||
| 2009-06-30 | $326.53M 10-K · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |